Search

Search Constraints

You searched for: Author/Creator Aieta, Michele

Search Results

1. A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?. Issue 9 (20th May 2020)

3. Association between neutropenia and response to ramucirumab and paclitaxel in patients with metastatic gastric cancer. Issue 6 (July 2020)

4. Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients. (June 2014)

5. Carboplatin plus etoposide in heavily pretreated castration-resistant prostate cancer patients. (June 2014)

7. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. (February 2016)

8. Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. (February 2016)

10. Docetaxel, oxaliplatin, 5FU, and trastuzumab as first-line therapy in patients with human epidermal receptor 2-positive advanced gastric or gastroesophageal junction cancer: Preliminary results of a phase II study. Issue 20 (May 2018)